Your browser doesn't support javascript.
loading
Ferroquine, the next generation antimalarial drug, has antitumor activity.
Kondratskyi, Artem; Kondratska, Kateryna; Vanden Abeele, Fabien; Gordienko, Dmitri; Dubois, Charlotte; Toillon, Robert-Allain; Slomianny, Christian; Lemière, Sébastien; Delcourt, Philippe; Dewailly, Etienne; Skryma, Roman; Biot, Christophe; Prevarskaya, Natalia.
Afiliação
  • Kondratskyi A; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France. Artem.Kondratskyi@inserm.fr.
  • Kondratska K; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France.
  • Vanden Abeele F; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France.
  • Gordienko D; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France.
  • Dubois C; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France.
  • Toillon RA; Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Center, Department of Oncology (KU Leuven) and Vesalius Research Center (VIB), Campus Gasthuisberg O&N4, Herestraat 49 - 912, B-3000, Leuven, Belgium.
  • Slomianny C; Inserm U908, Université Lille 1, Villeneuve d'Ascq, France.
  • Lemière S; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France.
  • Delcourt P; Univ. Lille Nord de France, EA 4515 - LGCgE - Université Lille 1, Cité scientifique, SN3, F-59655, Villeneuve d'Ascq, France.
  • Dewailly E; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France.
  • Skryma R; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France.
  • Biot C; Inserm, U-1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, SIRIC ONCOLille, Université Lille 1, Villeneuve d'Ascq, France.
  • Prevarskaya N; Univ. Lille 1, UGSF, UMR 8576 CNRS, 59650, Villeneuve d'Ascq, France.
Sci Rep ; 7(1): 15896, 2017 Nov 21.
Article em En | MEDLINE | ID: mdl-29162859

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Ferrosos / Aminoquinolinas / Antimaláricos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Ferrosos / Aminoquinolinas / Antimaláricos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França